175 related articles for article (PubMed ID: 22072393)
21. Radiotherapy in the treatment of hereditary breast cancer.
Pierce LJ; Haffty BG
Semin Radiat Oncol; 2011 Jan; 21(1):43-50. PubMed ID: 21134653
[TBL] [Abstract][Full Text] [Related]
22. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
Tapia T; Sanchez A; Vallejos M; Alvarez C; Moraga M; Smalley S; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2008 Jan; 107(2):281-8. PubMed ID: 17351744
[TBL] [Abstract][Full Text] [Related]
23. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
[TBL] [Abstract][Full Text] [Related]
24. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Renwick A; Thompson D; Seal S; Kelly P; Chagtai T; Ahmed M; North B; Jayatilake H; Barfoot R; Spanova K; McGuffog L; Evans DG; Eccles D; ; Easton DF; Stratton MR; Rahman N
Nat Genet; 2006 Aug; 38(8):873-5. PubMed ID: 16832357
[TBL] [Abstract][Full Text] [Related]
25. The founder mutations in the BRCA1, BRCA2, and ATM genes in Moroccan Jewish women with breast cancer.
Kreiss Y; Barak F; Baruch RG; Levy-Lahad E; Pras E; Friedman E
Genet Test; 2000; 4(4):403-7. PubMed ID: 11216667
[TBL] [Abstract][Full Text] [Related]
26. Hereditary breast cancer: new genetic developments, new therapeutic avenues.
Campeau PM; Foulkes WD; Tischkowitz MD
Hum Genet; 2008 Aug; 124(1):31-42. PubMed ID: 18575892
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
[TBL] [Abstract][Full Text] [Related]
28. Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.
Knappskog S; Chrisanthar R; Løkkevik E; Anker G; Østenstad B; Lundgren S; Risberg T; Mjaaland I; Leirvaag B; Miletic H; Lønning PE
Breast Cancer Res; 2012 Mar; 14(2):R47. PubMed ID: 22420423
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
Kontorovich T; Cohen Y; Nir U; Friedman E
Breast Cancer Res Treat; 2009 Jul; 116(1):195-200. PubMed ID: 18642075
[TBL] [Abstract][Full Text] [Related]
30. Ten genes for inherited breast cancer.
Walsh T; King MC
Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
[TBL] [Abstract][Full Text] [Related]
31. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
Graffeo R; Rana HQ; Conforti F; Bonanni B; Cardoso MJ; Paluch-Shimon S; Pagani O; Goldhirsch A; Partridge AH; Lambertini M; Garber JE
Breast; 2022 Oct; 65():32-40. PubMed ID: 35772246
[TBL] [Abstract][Full Text] [Related]
32. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Buys SS; Sandbach JF; Gammon A; Patel G; Kidd J; Brown KL; Sharma L; Saam J; Lancaster J; Daly MB
Cancer; 2017 May; 123(10):1721-1730. PubMed ID: 28085182
[TBL] [Abstract][Full Text] [Related]
33. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
Kleibl Z; Kristensen VN
Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
[TBL] [Abstract][Full Text] [Related]
34. ATM and genome maintenance: defining its role in breast cancer susceptibility.
Khanna KK; Chenevix-Trench G
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):247-62. PubMed ID: 15557798
[TBL] [Abstract][Full Text] [Related]
35. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.
Ding SL; Sheu LF; Yu JC; Yang TL; Chen BF; Leu FJ; Shen CY
Br J Cancer; 2004 May; 90(10):1995-2001. PubMed ID: 15138484
[TBL] [Abstract][Full Text] [Related]
36. Hereditary breast cancer: from molecular pathology to tailored therapies.
Tan DS; Marchiò C; Reis-Filho JS
J Clin Pathol; 2008 Oct; 61(10):1073-82. PubMed ID: 18682420
[TBL] [Abstract][Full Text] [Related]
37. The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
Oldenburg RA; Kroeze-Jansema K; Kraan J; Morreau H; Klijn JG; Hoogerbrugge N; Ligtenberg MJ; van Asperen CJ; Vasen HF; Meijers C; Meijers-Heijboer H; de Bock TH; Cornelisse CJ; Devilee P
Cancer Res; 2003 Dec; 63(23):8153-7. PubMed ID: 14678969
[TBL] [Abstract][Full Text] [Related]
38. Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients.
Flanagan JM; Munoz-Alegre M; Henderson S; Tang T; Sun P; Johnson N; Fletcher O; Dos Santos Silva I; Peto J; Boshoff C; Narod S; Petronis A
Hum Mol Genet; 2009 Apr; 18(7):1332-42. PubMed ID: 19153073
[TBL] [Abstract][Full Text] [Related]
39. Variants in the ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukemia.
Rudd MF; Sellick GS; Webb EL; Catovsky D; Houlston RS
Blood; 2006 Jul; 108(2):638-44. PubMed ID: 16574953
[TBL] [Abstract][Full Text] [Related]
40. On the proposed association of the ATM variants 5557G>A and IVS38-8T>C and bilateral breast cancer.
Langholz B; Bernstein JL; Bernstein L; Olsen JH; Børresen-Dale AL; Rosenstein BS; Gatti RA; ; Concannon P
Int J Cancer; 2006 Aug; 119(3):724-5. PubMed ID: 16496408
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
